Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature

Abstract Background Central precocious puberty (CPP) is a precocious puberty due to premature activation of the hypothalamic–pituitary‐gonadal axis (HPG). MKRN3 defects are well‐known causes of CPP, while DLK1 mutations were recently identified in a few patients with CPP. Methods The study was appro...

Full description

Bibliographic Details
Main Authors: Gaopin Yuan, Xiaohong Zhang, Shaofeng Liu, Tingli Chen
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.2087
_version_ 1797844759395434496
author Gaopin Yuan
Xiaohong Zhang
Shaofeng Liu
Tingli Chen
author_facet Gaopin Yuan
Xiaohong Zhang
Shaofeng Liu
Tingli Chen
author_sort Gaopin Yuan
collection DOAJ
description Abstract Background Central precocious puberty (CPP) is a precocious puberty due to premature activation of the hypothalamic–pituitary‐gonadal axis (HPG). MKRN3 defects are well‐known causes of CPP, while DLK1 mutations were recently identified in a few patients with CPP. Methods The study was approved by the Institutional Review and the scientific committee of the hospital. The clinical data were collected. Whole‐exome sequencing (WES) was performed to detect causative variants. Key words ‘DLK1’, ‘MKRN3’, and “central precocious puberty” were used for literature search in PubMed, Google Scholar, HGMD, and OMIM databases. Results The patient, a male, whose puberty began before age nine, had significant metabolic abnormalities including overweight, hyperlipidemia, and hyperuricemia. WES detected a recurrent frame‐shift mutation, NM_003836.5:c.479delC(p.P160fs*50) in DLK1 in the patient and his father. Conclusion The familial DLK1‐CPP was identified in China for the first time, which supported that short stature is predicted in patients with CPP without GnRHa treatment. Therefore, we recommend that children with DLK1‐CPP should be treated as early as possible to improve adult height. The patient in this study had persistent hyperuricemia, further suggests that this antiadipogenic factor represents a link between reproduction and metabolism.
first_indexed 2024-04-09T17:27:28Z
format Article
id doaj.art-c53ed749463b467b850ebb0470edd0f1
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-04-09T17:27:28Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-c53ed749463b467b850ebb0470edd0f12023-04-18T10:16:08ZengWileyMolecular Genetics & Genomic Medicine2324-92692022-12-011012n/an/a10.1002/mgg3.2087Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literatureGaopin Yuan0Xiaohong Zhang1Shaofeng Liu2Tingli Chen3Department of Pediatric endocrinology Quanzhou Women's and Children's Hospital Quanzhou ChinaDepartment of Pediatric endocrinology Quanzhou Women's and Children's Hospital Quanzhou ChinaDepartment of Pediatric Surgery Quanzhou Women's and Children's Hospital Quanzhou ChinaDepartment of Pediatric endocrinology Quanzhou Women's and Children's Hospital Quanzhou ChinaAbstract Background Central precocious puberty (CPP) is a precocious puberty due to premature activation of the hypothalamic–pituitary‐gonadal axis (HPG). MKRN3 defects are well‐known causes of CPP, while DLK1 mutations were recently identified in a few patients with CPP. Methods The study was approved by the Institutional Review and the scientific committee of the hospital. The clinical data were collected. Whole‐exome sequencing (WES) was performed to detect causative variants. Key words ‘DLK1’, ‘MKRN3’, and “central precocious puberty” were used for literature search in PubMed, Google Scholar, HGMD, and OMIM databases. Results The patient, a male, whose puberty began before age nine, had significant metabolic abnormalities including overweight, hyperlipidemia, and hyperuricemia. WES detected a recurrent frame‐shift mutation, NM_003836.5:c.479delC(p.P160fs*50) in DLK1 in the patient and his father. Conclusion The familial DLK1‐CPP was identified in China for the first time, which supported that short stature is predicted in patients with CPP without GnRHa treatment. Therefore, we recommend that children with DLK1‐CPP should be treated as early as possible to improve adult height. The patient in this study had persistent hyperuricemia, further suggests that this antiadipogenic factor represents a link between reproduction and metabolism.https://doi.org/10.1002/mgg3.2087central precocious pubertyDLK1hyperuricemiamaternal imprinting
spellingShingle Gaopin Yuan
Xiaohong Zhang
Shaofeng Liu
Tingli Chen
Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
Molecular Genetics & Genomic Medicine
central precocious puberty
DLK1
hyperuricemia
maternal imprinting
title Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
title_full Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
title_fullStr Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
title_full_unstemmed Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
title_short Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature
title_sort chinese familial central precocious puberty with hyperuricemia due to recurrent dlk1 mutation case report and review of the literature
topic central precocious puberty
DLK1
hyperuricemia
maternal imprinting
url https://doi.org/10.1002/mgg3.2087
work_keys_str_mv AT gaopinyuan chinesefamilialcentralprecociouspubertywithhyperuricemiaduetorecurrentdlk1mutationcasereportandreviewoftheliterature
AT xiaohongzhang chinesefamilialcentralprecociouspubertywithhyperuricemiaduetorecurrentdlk1mutationcasereportandreviewoftheliterature
AT shaofengliu chinesefamilialcentralprecociouspubertywithhyperuricemiaduetorecurrentdlk1mutationcasereportandreviewoftheliterature
AT tinglichen chinesefamilialcentralprecociouspubertywithhyperuricemiaduetorecurrentdlk1mutationcasereportandreviewoftheliterature